Prospective Phase II Validation of the Performance of a Prostate-Specific Membrane Antigen (PSMA) Radiotracer for Positron Emission Tomography-Multiparametric Magnetic Resonance (PET-mpMR) Imaging to Target Prostate Biopsy Via Transrectal Ultrasound (TRUS) -Magnetic Resonance Imaging (MRI) Fusion Technique
Latest Information Update: 30 Jun 2025
At a glance
- Drugs Fluorine 18 flotufolastat (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
Most Recent Events
- 24 Jun 2025 Status changed from not yet recruiting to recruiting.
- 04 Apr 2025 Planned initiation date changed from 13 Mar 2025 to 31 May 2025.
- 12 Mar 2025 New trial record